Phase III results in Genotype 1 naïve patients: Predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin

Paul Y. Kwo

Research output: Contribution to journalReview article

20 Scopus citations

Fingerprint Dive into the research topics of 'Phase III results in Genotype 1 naïve patients: Predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin'. Together they form a unique fingerprint.

Medicine & Life Sciences